je.st
news
Tag: biotechs
Foster City's Gilead seeks six-story lab: New expansion proposed for biotech's corporate campus
2016-04-07 17:23:53| Biotech - Topix.net
The multi-billion dollar success of the Foster City-headquartered Gilead Sciences is propelling the biopharmaceutical giant to continue expanding into its nearly 72-acre corporate campus, including a proposed new laboratory officials say could help the company save lives. The city's Planning Commission will meet Thursday, April 7, for a study session to review the proposal to demolish an existing single-story building and construct a six-story lab and office building that will bring it closer to fully building out the 2.5 million square feet of space to which Gilead holds entitlements.
Tags: corporate
proposed
expansion
campus
Looking for Sunshine in Biotech's Gloomy First-Quarter Performance
2016-04-01 05:05:08| Biotech - Topix.net
Pinch yourself. Check your pulse. Fog a mirror. You're alive! Congratulations, you just survived the worst quarterly performance for biotech stocks since 2002.
Tags: performance
sunshine
gloomy
biotechs
Microlin Bio buys Marina Biotech's nucleic acid therapeutics assets in cash-and-stock deal
2016-03-16 19:30:38| Biotech - Topix.net
Microlin Bio and Marina Biotech execute a term sheet under which Microlin intends to acquire Marina's nucleic acid therapeutics assets for 6.7M shares of Microlin stock and ~$1M in cash. Based on the recent price of $1.50 per share of MICB, the deal is valued at slightly more than $11M.
DEALTALK-Market turmoil drives small biotechs to big pharma
2016-02-16 07:44:27| Biotech - Topix.net
Feb 16 Numerous small biotechnology companies have been all but shut out of the capital markets, leaving many with no choice but to consider a sale to larger peers. The Nasdaq Biotech Index is down nearly 30 percent since September, when Democratic presidential candidate Hillary Clinton criticized drug companies' "price gouging" on Twitter and sparked concerns about a government crackdown on rising drug costs.
Gilead, Other Biotechs Selling Off On Market Weakness
2016-01-04 23:29:58| Biotech - Topix.net
Market mayhem continues, as Gilead Sciences, Inc. and other biotech companies are selling off on Monday's market weakness. Gilead Science's weekly performance is hovering around -5.75 percent and the issue has a YTD performance of -3.5 percent.
Tags: market
selling
weakness
gilead